Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|October 1, 2003
BOTOX AS HEADACHE HELP
Studies show that people treated with Botox (botulinum toxin, type A) for chronic migraine report less frequent, less intense headaches, and new data show that the use of Botox for headache prevention can reduce the number of emergency room visits by as much as 50 percent, according to Andrew Blumenfeld, M.D., chief of neurology at Kaiser Permanente in San Diego.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
4
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
5